Arbor Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-132
Closed -$12K 149
2019
Q2
$12K Buy
+132
New +$11.2K 0.01% 129
2017
Q2
Sell
-22,716
Closed -$1.64M 63
2017
Q1
$1.64M Buy
22,716
+1,059
+5% +$70.6K 1.44% 31
2016
Q4
$1.46K Buy
21,657
+963
+5% +$62.5K 1.14% 32
2016
Q3
$1.41M Sell
20,694
-158
-0.8% -$11.5K 1.2% 31
2016
Q2
$1.55M Buy
20,852
+7,681
+58% +$531K 1.47% 27
2016
Q1
$885K Buy
13,171
+7,395
+128% +$503K 0.91% 33
2015
Q4
$373K Buy
+5,776
New +$459K 0.41% 61

Other funds holding NVS

Arbor Wealth Management's NVS Position: Q3 2019 in Review

Arbor Wealth Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 132 shares — an estimated $12K sold.

Arbor Wealth Management first reported a position in NVS in Q4 2015 and held it in 7 quarters. The position peaked at $1.64M in Q1 2017. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Arbor Wealth Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • Arbor Wealth Management sold 132 Novartis shares in Q3 2019, an estimated $12K.
  • Arbor Wealth Management first reported a position in Novartis in Q4 2015 and held it in 7 quarters.
  • Arbor Wealth Management's Novartis position peaked at $1.64M in Q1 2017.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Arbor Wealth Management's 13F filing for Q3 2019, filed 6 Nov 2019.